- Home
- Supplements
- L-Arginine
- Erectile Dysfunction
L-Arginine for Erectile Dysfunction
L-arginine has modest but real evidence for mild-to-moderate erectile dysfunction, with meta-analyses showing improvement over placebo. Effects are smaller than PDE5 inhibitors but the combination outperforms either alone in trials. It addresses the vascular mechanism, so it fits cases with an endothelial component. Any new persistent ED still warrants cardiovascular screening — the arteries are the story.
Overview
No studies are currently linked to this pairing
This page reflects established pharmacology and conventional dosing rather than trial data attached to this concern in our library.
How It Works
Dosing & Protocol
| Context | Dose | Form | Timing |
|---|---|---|---|
| Common effective range | 3-6 g daily | L-arginine free base or HCl | Divided doses, empty stomach |
| Higher studied dose | 5 g twice daily | L-arginine | Morning and evening |
| Combination protocol | 1.7 g arginine with 40-120 mg pycnogenol | Combined product | Daily; among the better-supported combinations |
| Assessment window | 4-12 weeks | - | Use a validated score such as the IIEF rather than impressions |
Citrulline may be the better molecule
L-citrulline bypasses intestinal and hepatic arginase and raises plasma arginine more effectively than arginine itself, at lower doses.
Evidence
Erectile dysfunction is a cardiovascular warning sign
New erectile difficulty often precedes coronary disease by several years. See a doctor for cardiovascular and diabetes screening rather than treating it as a standalone supplement problem.
Safety
Avoid after a recent heart attack
A trial of high-dose arginine after myocardial infarction was stopped early because of increased mortality in the arginine group. Do not use it in this setting.
Interactions & Conflicts
| Interacts with | Severity | Mechanism | Action |
|---|---|---|---|
| Nitrates such as GTN or isosorbide | high | Additive nitric oxide-mediated vasodilation and hypotension | Avoid |
| Sildenafil, tadalafil and other PDE5 inhibitors | moderate | Additive blood pressure lowering; combination has been studied but needs supervision | Only combine with medical guidance |
| Antihypertensives | moderate | Additive hypotension | Monitor blood pressure when starting |
| Recent myocardial infarction or active herpes | high | Increased mortality signal post-MI; viral replication needs arginine | Avoid |
References
Frequently Asked Questions
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.